Nerve Block for Postoperative Pain
(POPPY Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
To assess the benefit of using an additional nerve block during minimally invasive pituitary surgery, to improve pain management after surgery. The medication (Bupivacaine) or a placebo (saline) will be injected during surgery and patients will be asked about their level of pain at multiple time points in the first 24 hours following surgery. Some patients will be randomized to a third, sham group that do not receive any additional injection. The aim is to improve patient outcomes and reduce the need for pain medication after surgery.
Who Is on the Research Team?
Dr. Kesava Reddy, MD
Principal Investigator
Hamilton Health Sciences Corporatin
Are You a Good Fit for This Trial?
This trial is for individuals undergoing minimally invasive pituitary surgery who need postoperative pain management. Participants must meet certain health criteria to be eligible, but specific inclusion and exclusion details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Treatment
Participants undergo minimally invasive pituitary surgery with either bupivacaine injection, placebo injection, or no injection for pain management
Immediate Post-operative Monitoring
Participants' pain levels and post-operative complications are monitored at multiple time points within the first 24 hours after surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment, including post-operative bleeding, length of stay, and analgesic requirements
What Are the Treatments Tested in This Trial?
Interventions
- Sphenopalatine Ganglion Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hamilton Health Sciences Corporation
Lead Sponsor